A new study is examining how age may shape the clinical and nutritional outcomes of endoscopic retrograde cholangiopancreatography, or ERCP, in children living with chronic pancreatitis. Published in Pediatric Research on August 6, 2026, the research by Zhu, Zhang, Ding and colleagues focuses on a procedure that can relieve blockages and pressure within the pancreatic and biliary ducts, but whose benefits and risks may not be identical across infancy, childhood and adolescence.
Chronic pancreatitis is a long-term inflammatory disease in which repeated or persistent injury damages the pancreas. The organ has two major roles: it produces digestive enzymes that break down food, and it releases hormones such as insulin that regulate blood glucose. In children, chronic pancreatitis can lead to recurrent abdominal pain, impaired digestion, poor weight gain and deficiencies of fat-soluble vitamins, including vitamins A, D, E and K. The condition may also disrupt school attendance, physical activity and overall quality of life.
ERCP is an endoscopic technique that allows specialists to access the pancreatic and bile ducts without open surgery. During the procedure, a flexible camera is guided through the mouth, stomach and duodenum to the opening where the ducts drain into the intestine. Contrast material can then be introduced to outline the duct system on X-ray images. If physicians find a narrowing, stone or obstructing lesion, they may insert a small plastic or metal stent, widen the narrowed area, or remove obstructing material.
In adults, ERCP is now used primarily for treatment rather than diagnosis because less invasive imaging methods, such as magnetic resonance cholangiopancreatography, can often provide detailed pictures of the ducts. In children with chronic pancreatitis, however, ERCP may still have an important therapeutic role. By improving the flow of pancreatic secretions, the procedure can reduce ductal pressure and potentially ease pain associated with obstruction. It may also help manage structural complications that cannot be treated adequately with medication alone.
The new study addresses a central question in pediatric gastroenterology: does a child’s age influence what happens after ERCP? Age can affect nearly every stage of care, from the technical difficulty of advancing endoscopic equipment to the choice of anesthesia, the size of available instruments and the child’s ability to describe symptoms. Younger children also have different nutritional requirements and smaller body reserves, meaning that recurrent pain, vomiting or malabsorption may affect growth more rapidly than in older patients.
Nutritional status is especially important in pediatric chronic pancreatitis because pancreatic damage can reduce the delivery of digestive enzymes to the small intestine. Without sufficient pancreatic enzymes, fats and other nutrients may not be absorbed efficiently, a condition known as exocrine pancreatic insufficiency. Children may require pancreatic enzyme replacement therapy with meals and snacks, individualized dietary support and monitoring of growth. An intervention that reduces pain or improves duct drainage could therefore have consequences extending beyond symptom control, potentially influencing eating patterns and nutritional recovery.
At the same time, ERCP is an invasive procedure with recognized risks. The most common serious complication is post-ERCP pancreatitis, in which manipulation of the pancreatic duct triggers a new inflammatory episode. Other complications can include bleeding, infection, perforation and problems related to stent placement or removal. Because children differ in anatomy, disease cause and developmental stage, evaluating outcomes by age may help physicians balance the possible benefits of ductal intervention against these risks.
The investigators’ work is designed to evaluate age-associated clinical and nutritional outcomes after ERCP in pediatric chronic pancreatitis. That framing is important because procedural success alone does not capture the full impact of treatment. A technically successful ERCP may still be followed by recurrent pain, additional procedures or persistent nutritional impairment. Conversely, improvements in symptoms, weight gain, growth and nutritional markers could indicate that restoring ductal drainage is providing a broader benefit for a child’s health.
The information available for this report identifies the study’s objective and publication details but does not provide its numerical results, patient counts or age-specific findings. Those data will be essential for determining whether younger and older children experience different rates of complications, symptom improvement, repeat intervention or nutritional recovery. Until the complete findings are assessed, the study’s significance lies in its focus: pediatric ERCP should be evaluated not only as a technical procedure, but as part of a longer-term strategy for protecting growth, digestion and quality of life in children with chronic pancreatitis.
Subject of Research: Age-associated clinical and nutritional outcomes following ERCP in children with chronic pancreatitis.
Article Title: Age-associated outcomes of ERCP in pediatric chronic pancreatitis.
Article References: Zhu, Y., Zhang, T., Ding, S. et al. Age-associated outcomes of ERCP in pediatric chronic pancreatitis. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05351-3
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41390-026-05351-3
Keywords: pediatric chronic pancreatitis, ERCP, endoscopy, pancreatic ducts, nutrition, growth, gastrointestinal disease, children, clinical outcomes
